Is NEUP or NMRA more undervalued in 2026?

CirclFi compares Neuphoria Therapeutics Inc. (NEUP) and Neumora Therapeutics, Inc. (NMRA) using 13 institutional-grade valuation models. NEUP has a Quality of Company score of 5.4/10 while NMRA scores 3.8/10.

Which is a better buy — NEUP or NMRA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NEUP and NMRA valuations compare?

NEUP at $5.36 and NMRA at $1.88 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NEUP vs NMRA Valuation Comparison 2026 — Intrinsic Value Analysis

NEUP

Biotechnology

Neuphoria Therapeutics Inc.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$5.36

Last close

Models

10/13

Active

NMRA

Biotechnology

Neumora Therapeutics, Inc.

Quality

3.8

out of 10

Value Trap

LOW

Price

$1.88

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	NEUP Fair Value	NEUP Upside	NMRA Fair Value	NMRA Upside
Bayesian DCF	Intrinsic	$3.75	-30.0%	$0.82	-56.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.61	-88.6%	$1.16	-38.5%
Dynamic NAV	Asset-Based	$6.53	+21.8%	$1.55	-17.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NEUP vs NMRA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NEUP vs NMRA — Which Stock Is More Undervalued?

NEUP scores higher with a 5.4/10 quality rating vs NMRA's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Neuphoria Therapeutics Inc. (NEUP) and Neumora Therapeutics, Inc. (NMRA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NEUP currently trades at $5.36 with a QOC of 5.4/10, while NMRA trades at $1.88 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).